Comprehensive data management and streamlining solution for business-critical data (Data Stream)
The FDA RFI response deadline of 19 October 2026 at 12:00 p.m. Eastern Daylight Time has passed. SAM.gov still lists the notice as published; its current record shows no award or cancellation.
SAM.gov
Overview
The Food and Drug Administration seeks information for planning and market research on technical capabilities to provide the services described for its Data Stream requirements. The RFI refers to an attached Statement of Work for the full service scope. It is not a solicitation or a commitment by FDA; the agency says responses will not lead to a selection or contract award and will not be compensated. Responses were due on 19 October 2026 at 12:00 p.m. Eastern Daylight Time. That deadline has passed. SAM.gov still lists the notice as published and shows no award or cancellation.
Information based on the public notice
Ask about this tender
What the buyer needs
Planning and market research to assess technical capabilities for the FDA's Data Stream service needs, with detailed service scope referred to an attached Statement of Work.
- FDA welcomes responses from all interested businesses. The notice says it will not acknowledge receipt, answer questions, report review outcomes, hold discussions, or select or award a contract on the basis of responses.
Tender details
- Buyer
- Food and Drug Administration
- Country
United States
- Procedure
- Sources Sought
- Classification
- IT, software and telecoms · NAICS 541512 · PSC DA01
- Notice reference
- 33052ba44678476e9ba02941ea419320 · FDA-RFI-27-1251190
- RFI number
- FDA-RFI-27-1251190
- Response deadline
- 19 October 2026 at 12:00 p.m. Eastern Daylight Time (16:00 UTC); passed
- Place of performance
- Silver Spring, Maryland 20993, United States
- NAICS code
- 541512
- Primary contact telephone
- 2404028856
- Current SAM.gov record
- Published; not archived or cancelled; no award details are present in the response
What to check in the tender documents
- The notice body does not state the project value, detailed service requirements, response method, or contract performance period; it refers to an attached Statement of Work for the full service scope.
Original notice
Read the original description
Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream)
Official source: SAM.gov ↗
Notice updates
October 20, 2026 · Version 4
Buyer updated · Deadline information updated · Summary and analysis updated · Tender facts updated · Original notice updated · Deadline updated · Source notice details updated · Source references updated · Status changed · Notice update added
Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream)
<p>This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the technical capabilities for providing the full range of services described in the Statement of Work (SOW) attached at the end. FDA will use this market research information to assess the market's capability to successfully meet the Data Strem requirements. <br /> FDA welcomes responses from all interested businesses. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information.<br /> Acknowledgment of receipt of responses will not be made, no questions will be answered, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required. </p>
October 18, 2026 · Version 3
Classification updated
Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream)
This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the technical capabilities for providing the full range of services described in the Statement of Work (SOW) attached at the end. FDA will use this market research information to assess the market's capability to successfully meet the Data Strem requirements. FDA welcomes responses from all interested businesses. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information. Acknowledgment of receipt of responses will not be made, no questions will be answered, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required.
October 12, 2026 · Version 2
Deadline information updated · Summary and analysis updated · Original notice updated · Deadline updated · Source references updated
Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream)
This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the technical capabilities for providing the full range of services described in the Statement of Work (SOW) attached at the end. FDA will use this market research information to assess the market's capability to successfully meet the Data Strem requirements. FDA welcomes responses from all interested businesses. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information. Acknowledgment of receipt of responses will not be made, no questions will be answered, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required.
October 12, 2026 · Version 1
Published
Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream)
https://sam.gov/opp/33052ba44678476e9ba02941ea419320/view
Source retrieved: 2026-10-20T19:11:56.596603Z